NEWS & More

THE LATEST NEWS AND EVENTS

At health care’s biggest investor conference, AI’s high hopes collided with skepticism - STAT article
Jan 18, 2024

Unveiling the AI Dominance in Biopharma: STAT Post JPM Conference Insights

Jan 17, 2024

Servier and Aitia Announce a New Collaboration Focused on Parkinson’s Disease

Servier Will Apply Aitia's Digital Twins to Parkinson’s Drug
Jan 08, 2024

Servier Will Apply Aitia’s Gemini Digital Twins to Parkinson’s Drug

Aitia Servier Partnership 300x300 1
Nov 29, 2023

Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment

CRL
Nov 16, 2023

Charles River and Aitia Join Forces to Harness AI and Gemini Digital Twins in Advancing Neurodegenerative and Oncology Research

Nov 13, 2023

Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology

Sydley 300x300 1
Nov 09, 2023

Hear What Colin Hill had to say to Sidley on AI Use in Drug Discovery

Nov 08, 2023

Cytoskeleton Genes Underlying Onset and Progression in Multiple Neurodegenerative Disorders Discovered through Aitia’s Digital Twins to be Presented at SfN 2023

Oct 19, 2023

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023

Webinar Video
Sep 20, 2023

Webinar | From the beta-amyloid hypothesis to AI-driven discoveries of novel biomarkers and breakthrough drugs in Alzheimer’s Disease